Why the study?
Does transaxillary Impella 5.5 provide haemodynamic support in a patient with cardiogenic shock due to Takotsubo syndrome?
Does transaxillary Impella 5.5 provide haemodynamic support in a patient with cardiogenic shock due to Takotsubo syndrome?
First-in-man report demonstrating successful use of transaxillary Impella 5.5 for haemodynamic support in cardiogenic shock due to Takotsubo syndrome.
Answers are grounded in this paper and cite their sources.
May support transaxillary Impella 5.5 feasibility in Takotsubo shock; leaves open efficacy, safety, and generalizability.
We present the first-in-man implantation of a transaxillary Impella 5.5 in a patient with TTS. The patient benefitted from Impella 5.5 therapy with full haemodynamic support and venting of the left ventricle.
No takes yet. Share an insight, caveat, or question.
Mackensen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: